Direxion Launches mRNA ETF (MSGR)

/PRNewswire/ -- Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR). MSGR invests in companies believed to be at the forefront of the...

Related Keywords

United States ,Canada ,David Mazza ,James Doyle ,Bloomberg ,Vertex Pharmaceuticals Inc ,Biotechnology Pharmaceuticals ,Drug Administration ,Arrowhead Pharmaceuticals Inc ,Beigene Ltd ,Maravai Lifesciences Holdings Inc ,Alnylam Pharmaceuticals Inc ,Dicerna Pharmaceuticals Inc ,Index Holdings ,Technology Index ,Moderna Inc ,Managing Director ,Bloomberg Finance ,Direxion Shares ,Shares Risks ,Emergency Use Authorization ,Non Diversification Risk ,Tracking Risk ,Index Strategy Risk ,Biotechnology Industry Risk ,Healthcare Sector Risk ,Market Disruption Risk ,Foreign Securities Risk ,Direxion ,